학술논문

Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study
Document Type
Article
Source
In Annals of Oncology February 2016 27(2):314-318
Subject
Language
ISSN
0923-7534